An interventional study of Extra-peritoneal in Colostomy Stoma, Cancer of Colon and Surgery, sponsored by Swansea Bay University Health Board. Completed at 3 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-18.
Sponsored by Swansea Bay University Health Board · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 107 studies in Colonic Neoplasms with a site in United Kingdom — 16 open to participants now, 25 under way, 6 of them phase 3. Colonic Neoplasms · United Kingdom.
Among the 107 studies in Colonic Neoplasms with a site in United Kingdom, this one is the 71st largest by enrollment of the 80 interventional ones that give a count, is one of 7 that started in 2021, is one of 20 with no phase, and was the 86th registered.
2,457 studies on the registry are indexed under Colonic Neoplasms; 456 are open to participants now.
Browse Colonic Neoplasms studies →16 of the 107 studies in Colonic Neoplasms with a site in United Kingdom are open now. Recruiting first, the newest first:
Solstice Oncology, Inc. · Sites in United Kingdom, United States, Belgium and 3 more countries
Ages 18+
Incyte Corporation · Sites in United Kingdom, United States, Argentina and 19 more countries
Ages 18+
Imperial College London · Sites in United Kingdom
Ages 18+ · Healthy volunteers
Merck Sharp & Dohme LLC · Sites in United Kingdom, United States, Argentina and 26 more countries
Ages 18+
GlaxoSmithKline · Sites in United Kingdom, Belgium, Italy and 3 more countries
Ages 18+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 326 Colonic Neoplasms studies recruiting now, 202 (62%) set no upper age limit and 72 (22%) stop at 75 or younger; 19 take children under 18; 35 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
107 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 20 · Phase 2 28 · Phase 3 32
First in 1994; this study’s year is marked. 7 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 23 is below the median of 75 across 1,711 interventional studies indexed under Colonic Neoplasms.
Median enrollment 173 across the 80 interventional studies, 300 across the 20 observational. Of the 60 that completed or were terminated, 14 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
37 of 107 have an industry lead sponsor. The 10 most frequent:
Swansea Bay University Health Board is the lead sponsor of 9 studies on the registry; 5 are open to participants now.
Swansea Bay University Health Board has 1 study filed under Colonic Neoplasms — fewer than ten, so there is no comparison to draw.
4 of the studies in Colonic Neoplasms with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06567782GlaxoSmithKlineA Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer | 2026-11-23 |
| NCT04103372Imperial College LondonPre-therapeutic MRI Assessment of Early-Stage Rectal Cancer and Significant Rectal Polyps to Avoid Major Resectional Surgery | 2026-12-31 |
| NCT05433142Xencor, Inc.Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma | 2027-02 |
| NCT06447064Imperial College LondonCancer Loyalty Card Study 2 (CLOCS-2) | 2027-02 |
Add all 4 to your calendar (.ics) → With an account.
Among the 107 studies in Colonic Neoplasms with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A randomised controlled feasibility study to compare two surgery techniques in the formation of a permanent end colostomy; the trans-peritoneal(TP) technique - currently, the most commonly used technique and the investigational extra-peritoneal(EP) technique, which has been reported in small studies to reduce the risk of parastomal hernia . This feasibility study will primarily aim to determine the feasibility viability of progression to a full multi-centre trial and test study design acceptability for participants. Participants will be asked to consent to be randomised to either the TP or EP procedure during surgery. Following surgery, participants will be followed up to a maximum of 12 months and asked to complete quality of life questionnaires (EQ5D and Colostomy Impact Score). Participant data will also be accessed by research teams at site to collect data on stoma appliance use and complications.
This feasibility study is a multi-centre, single (patient) blinded, randomised controlled trial (RCT). Co-ordination and trial management will be led from Swansea Trials Unit (STU).
The study will take place across 3 sites: Swansea Bay University Health Board (SBUHB); Aneurin Bevan University Health Board and Cardiff and Vale University Health Board. Surgeons at all three sites have experience with both interventional extra-peritoneal surgical technique and the most commonly used transperitoneal technique.
The investigators aim to recruit 60 participants over 12 months. Local recruitment will be co-ordinated by PIs and research teams. Recruitment is aimed to be equally distributed across all sites. Participants will be equally randomised by arm in each of the three sites: to receive the EP colostomy formation (Intervention) or the standard transperitoneal (TP) technique. Participants will remain blinded as to their treatment until the close of the study.
Data collection will be performed by the clinical and research teams, with support from PIs. Data will be stored centrally in REDCap (Research Electronic Data Capture) software.
The investigators will explore whether it is possible to establish a research infrastructure in which data can be collected and co-ordinated across sites and for patients to be followed up effectively. The investigators will also look to demonstrate standardisation of the operative technique for EP stoma formation and to determine which outcome measures a future trial should explore. This feasibility trial be evaluated against ACCEPT progression criteria.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Surgery technique in the formation of permanent end colostomy
Surgery technique in the formation of permanent end colostomy
Procedure: Extra-peritoneal
Surgery procedure: a non-mesh prophylactic surgical technique to prevent PH
Assessing the feasibility of the trial based on recruitment rate
number of eligible patients who consent
Time frame: Consent
Assessing the feasibility of the trial based on data completeness
% follow up data collected for 80% of participants
Time frame: Week 6
Assessing the feasibility of the trial based on surgeon involvement
number of surgeons at sites willing to be involved in the trial
Time frame: set up
Assessing the feasibility of the trial based on recruitment within sites
number of patients recruited at each site to be at least 10
Time frame: consent
Assessing the feasibility of the trial based on surgeon training
ability to successfully train surgeons taking part
Time frame: set up
Assessing the feasibility of the trial based on surgeon compliance with the intervention
80% compliance with the correct technique required
Time frame: month 12
Assessing the feasibility of the trial based on collection of key outcomes
collection of colostomy impact score, EQ-5D and rate of parastomal hernia
Time frame: week 6, month 6 and month 12
Assessing the feasibility of the trial based on overall QoL reported in intervention group compared with standard care group
QoL data to be 80% or more of that in the standard care group
Time frame: week 6, month 6 and month 12
Plan to share: No — No current plan to share IPD but will discuss with study team if and/or when the request arises.
No publications or documents are linked to this record.
Ran from Dec 2021 to primary completion in Mar 2024, 27 months.
Of 382 non-industry interventional studies with no phase under Colonic Neoplasms, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 55. This study's 27 months is below that.
Counting every sponsor, half of 404 studies reached it within 30 months; a quarter within 16 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Swansea Bay University Health Board